NFKB1 and central nervous system cancer: Given that GBP or PGB binding on α2δ subunits is able to inhibit this factor in neuroblastoma and glioma cells (Park et al., 2008), the anti-inflammatory effect of PGB could be due to the blockade of NF-kB pathway activation.